Off the wire
• Feature: Why migrants are making many Sicilian citizens anxious  • Aviation orders accumulate to 30 bln USD at Dubai Airshow  • Czech policemen leave for Schengen borders guarding mission in Slovenia  • 1st LD: 6.2-magnitude quake jolts off Alaska's Aleutian Islands -- USGS  • UNIFIL cooperates with Lebanon in spy case  • Israeli defense chief believes Russian plane crash "a terror attack"  • Anti-doping commission delivers damning blow to Russian athletics  • Sweden sees record number of weekly asylum admissions  • Maersk Oil to acquire shares in onshore exploration licenses  • Real Sociedad sack David Moyes  
You are here: 　 Home

Chinese pharmaceutical group enters Lithuanian market

Xinhua, November 10, 2015 Adjust font size:

Chinese pharmaceutical company Tasly expanded its activities in Lithuania, the company said in a statement here on Monday.

The company this November began the sale of its premium segment detoxifying teas in Lithuanian pharmacies.

Tasly Group in a statement said it plans to expand in the Baltic country and elsewhere in Europe.

Established in 1994, the group focuses on biological medicine as its core business. The company is on the list of 500 largest pharmaceutical and medical companies in China.

The group's revenues reached 1.75 billion euros (1.88 billion U.S. dollars) in 2014, according to the statement. Endit